Replies to post #35667 on Humanigen Inc (HGENQ)

[cowtown jay]

The $200M S-3 is not a completed document. It is a contingency plan, and it will be enacted, if needed.

Why wouldn't it be needed?

One reason could be because of the amount of revenue we may raise through Clinigen.

But another reason could be because we may have produced about $300M in product beyond the company's stated goal of 100K treatments.

Possible OWS-type funding from France, the UK, and the US may also reduce our cash requirements.

So it makes sense to me that the company is not able to quantify the amount of equity funding, if any, they may need with another S-3.